{"AllianceGenome": "7579", "HGNC": "7579", "MIM": "160775", "_id": "4627", "_version": 1, "accession": {"genomic": ["AB839000.1", "AB839084.1", "AB839085.1", "CH471095.1", "CP068256.2", "DQ304679.1", "FO393418.1", "HI574092.1", "KF457437.1", "KF457439.1", "KF457440.1", "KF511473.1", "NC_000022.11", "NC_060946.1", "NG_011884.2", "Z82215.1"], "protein": ["AAA20904.1", "AAA36349.1", "AAA59888.1", "AAA61765.1", "AAH49849.1", "AAH90921.1", "ABC25483.1", "ALX00019.1", "BAA01989.1", "BAC85130.1", "BAD52439.1", "BAF84298.1", "BAG06729.1", "BAG65583.1", "CAD89954.1", "CAG30412.1", "CBX47535.1", "EAW60096.1", "EAW60097.1", "EAW60098.1", "NP_002464.1", "P35579.4", "WKR38968.1"], "rna": ["AA420536.1", "AB191263.1", "AB290175.1", "AK025219.1", "AK025393.1", "AK131080.1", "AK291609.1", "AK304840.1", "AL832639.2", "BC011915.2", "BC049849.1", "BC090921.1", "BC111387.1", "CD614930.1", "CR456526.1", "D11393.1", "DC296130.1", "KU159427.1", "L29141.1", "M31013.1", "M69180.1", "M81105.1", "NM_002473.6", "OQ689691.1"], "translation": [{"protein": "BAG65583.1", "rna": "AK304840.1"}, {"protein": "ALX00019.1", "rna": "KU159427.1"}, {"protein": "AAA59888.1", "rna": "M81105.1"}, {"protein": "AAH90921.1", "rna": "BC090921.1"}, {"protein": "BAA01989.1", "rna": "D11393.1"}, {"protein": "BAC85130.1", "rna": "AK131080.1"}, {"protein": "WKR38968.1", "rna": "OQ689691.1"}, {"protein": "BAG06729.1", "rna": "AB290175.1"}, {"protein": "AAH49849.1", "rna": "BC049849.1"}, {"protein": "AAA61765.1", "rna": "M69180.1"}, {"protein": "NP_002464.1", "rna": "NM_002473.6"}, {"protein": "BAF84298.1", "rna": "AK291609.1"}, {"protein": "CAD89954.1", "rna": "AL832639.2"}, {"protein": "CAG30412.1", "rna": "CR456526.1"}, {"protein": "AAA20904.1", "rna": "L29141.1"}, {"protein": "AAA36349.1", "rna": "M31013.1"}, {"protein": "BAD52439.1", "rna": "AB191263.1"}]}, "alias": ["BDPLT6", "DFNA17", "EPSTS", "FTNS", "MATINS", "MHA", "NMHC-II-A", "NMMHC-IIA", "NMMHCA"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2018-02-20T05:00:00.000Z", "disease_label": "macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss", "gcep": "Hearing Loss Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0015912", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6801442-c490-44a0-9a60-84ab5b20f7ac-2018-02-20T050000.000Z", "sop": "SOP5"}}, "ensembl": {"gene": "ENSG00000100345", "protein": ["ENSP00000216181", "ENSP00000384631", "ENSP00000414852", "ENSP00000509816", "ENSP00000510189", "ENSP00000510688"], "transcript": ["ENST00000216181", "ENST00000401701", "ENST00000456729", "ENST00000459960", "ENST00000463027", "ENST00000472210", "ENST00000473022", "ENST00000475726", "ENST00000477189", "ENST00000486218", "ENST00000495928", "ENST00000685187", "ENST00000685191", "ENST00000685708", "ENST00000685801", "ENST00000687820", "ENST00000687922", "ENST00000688137", "ENST00000690244", "ENST00000691109", "ENST00000691296", "ENST00000691687", "ENST00000692930"], "translation": [{"protein": "ENSP00000216181", "rna": "ENST00000216181"}, {"protein": "ENSP00000510688", "rna": "ENST00000685801"}, {"protein": "ENSP00000510189", "rna": "ENST00000688137"}, {"protein": "ENSP00000384631", "rna": "ENST00000401701"}, {"protein": "ENSP00000509816", "rna": "ENST00000691296"}, {"protein": "ENSP00000414852", "rna": "ENST00000456729"}], "type_of_gene": "protein_coding"}, "entrezgene": "4627", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 71.9998576104, "exp_mis": 852.616809416, "exp_syn": 413.960146819, "lof_z": 8.17186192944358, "mis_z": 5.5883993180404, "mu_lof": 4.97498089612e-06, "mu_mis": 7.52186081732e-05, "mu_syn": 3.57012548902e-05, "n_lof": 2.0, "n_mis": 519.0, "n_syn": 419.0, "p_li": 0.999999999912023, "p_null": 2.8170225087734e-27, "p_rec": 8.79766471006807e-11, "syn_z": -0.153564962079381}, "bp": 5883, "cds_end": 36745281, "cds_start": 36678713, "n_exons": 40, "nonpsych": {"exp_lof": 64.3559780609, "exp_mis": 770.889669639, "exp_syn": 373.863061615, "lof_z": 7.63370918966679, "mis_z": 5.62953811280597, "mu_lof": 4.97498089612e-06, "mu_mis": 7.52186081732e-05, "mu_syn": 3.57012548902e-05, "n_lof": 2.0, "n_mis": 461.0, "n_syn": 380.0, "p_li": 0.999999998660312, "p_null": 2.61014576879024e-24, "p_rec": 1.33968813744774e-09, "syn_z": -0.199827971198333}, "nontcga": {"exp_lof": 66.1608356893, "exp_mis": 784.328485685, "exp_syn": 380.764339289, "lof_z": 7.7812748339858, "mis_z": 5.50276106780258, "mu_lof": 4.97498089612e-06, "mu_mis": 7.52186081732e-05, "mu_syn": 3.57012548902e-05, "n_lof": 2.0, "n_mis": 475.0, "n_syn": 383.0, "p_li": 0.999999999249973, "p_null": 5.19956513345043e-25, "p_rec": 7.50026681518576e-10, "syn_z": -0.0725450338759211}, "transcript": "ENST00000216181.5"}, "exons": [{"cdsend": 36349236, "cdsstart": 36282667, "chr": "22", "position": [[36281279, 36282785], [36284092, 36284265], [36284402, 36284511], [36285120, 36285329], [36285657, 36285781], [36285864, 36285953], [36286717, 36286846], [36288251, 36288413], [36288726, 36288939], [36289084, 36289297], [36291985, 36292234], [36293328, 36293481], [36293758, 36293863], [36294091, 36294298], [36294931, 36295076], [36295504, 36295717], [36296842, 36297014], [36298918, 36299042], [36300126, 36300264], [36300850, 36301057], [36301533, 36301665], [36302567, 36302676], [36303994, 36304155], [36305032, 36305102], [36305929, 36306051], [36306413, 36306607], [36309281, 36309396], [36312048, 36312222], [36314144, 36314318], [36316516, 36316669], [36318206, 36318325], [36319539, 36319635], [36320219, 36320363], [36320797, 36320896], [36321757, 36321821], [36322428, 36322521], [36326567, 36326661], [36327460, 36327488], [36341369, 36341526], [36348903, 36349255], [36387806, 36387967]], "strand": -1, "transcript": "NM_002473", "txend": 36387967, "txstart": 36281279}], "exons_hg19": [{"cdsend": 36745281, "cdsstart": 36678713, "chr": "22", "position": [[36677325, 36678831], [36680138, 36680311], [36680448, 36680557], [36681166, 36681375], [36681703, 36681827], [36681910, 36681999], [36682763, 36682892], [36684297, 36684459], [36684772, 36684985], [36685130, 36685343], [36688031, 36688280], [36689374, 36689527], [36689804, 36689909], [36690137, 36690344], [36690977, 36691122], [36691550, 36691763], [36692888, 36693060], [36694964, 36695088], [36696172, 36696310], [36696896, 36697103], [36697579, 36697711], [36698613, 36698722], [36700040, 36700201], [36701078, 36701148], [36701975, 36702097], [36702459, 36702653], [36705326, 36705441], [36708093, 36708267], [36710189, 36710363], [36712561, 36712714], [36714251, 36714370], [36715584, 36715680], [36716264, 36716408], [36716842, 36716941], [36717802, 36717866], [36718473, 36718566], [36722612, 36722706], [36723505, 36723533], [36737414, 36737571], [36744948, 36745300], [36783851, 36784012]], "strand": -1, "transcript": "NM_002473", "txend": 36784012, "txstart": 36677325}], "generif": [{"pubmed": 11590545, "text": "mutations cause a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes; hence, the name \"MYHIIA syndrome\" is proposed to encompass all of these disorders"}, {"pubmed": 11935325, "text": "mutation in epstein syndrome"}, {"pubmed": 12421915, "text": "Motor protein nonmuscle myosin heavy chain-IIA and CXCR$ colocalize at the leading edge of migrating T lymphocytes, together with filamentous actin and myosin light chain."}, {"pubmed": 12500226, "text": "A major role is indicated for the NMMHC-IIA abnormality in the pathogenesis of leukocyte, platelet, and kidney defects in Fechtner syndrome."}, {"pubmed": 12621333, "text": "A single base pair transition in MYH9, resulting in an amino acid substitution D1424N, is responsible for macrothrombocytopenia and hearing loss in the kindred under study."}, {"pubmed": 12649151, "text": "The Asp1424Asn mutation in the MYH9 gene causes the May-Hegglin anomaly, Fechtner syndrome, Sebastian syndrome, & Epstein syndrome, which result from a highly unstable protein & failure to reorganize the megakaryocyte cytoskeleton for platelet production."}, {"pubmed": 12792306, "text": "MYH9 gene is implicated in May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome and Epstein syndrome which are autosomal dominant macrothrombocytopenias."}, {"pubmed": 12800156, "text": "In a case of anaplastic large cell lymphoma, a portion of MYH9 is found to be fused to the ALK gene in a novel chromosomal abnormality, t(2;22)(p23;q11.2)."}, {"pubmed": 14706930, "text": "Myosin heavy polypeptide 9 (MYH9) colocalizes with actin stress fibers in mammalian cells."}, {"pubmed": 15477207, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 15479433, "text": "sCD163-NMMHCA complexes were present in activated T lymphocytes after incubation with shed sCD163"}, {"pubmed": 15555549, "text": "Here targeted gene disruption was performed to understand fundamental as well as pathological role of the gene for NMMHCA, MYH9."}, {"pubmed": 15749830, "text": "Two cleavage sites on NMHC-A, Asp-1153 and Asp-1948, at which it is cleaved during apoptosis, were determined."}, {"pubmed": 15865432, "text": "Casein kinase 2 phosphorylation of the myosin-IIA heavy chain protects against Ca2+-regulated S100 family member MTS1-induced filament disassembly and inhibition of assembly of nonmuscle myosin-IIA filaments."}, {"pubmed": 16162639, "text": "Haploinsufficiency of NMMHC-IIA in megakaryocytic lineage is the mechanism of macrothrombocytopenia consequent to MYH9 mutations, whereas in granulocytes a dominant-negative effect of mutant allele is involved in the formation of inclusion bodies."}, {"pubmed": 16403913, "text": "VEGF, extracellular matrix, and intracellular motor protein MyH9 are all essential for the novel function of nucleolin in angiogenesis."}, {"pubmed": 16567366, "text": "Results suggest that MYH9 mediates the binding of oviductal glycoprotein to human sperm."}, {"pubmed": 16806139, "text": "Mutation of MYH9 gene exists in cases of Chinese MYH9-related disease. In the two families, the point mutation was located in exon 38(G5521A), and the transference rule of the MYH9 gene mutation is corresponding with clinical phenotype distribution."}, {"pubmed": 17020881, "text": "myosin IIA and IIB isoforms are regulated by different signaling pathways to perform distinct cellular activities"}, {"pubmed": 17241369, "text": "Patients carrying R702 mutations had significantly larger platelets than those with other MYH9 mutations"}, {"pubmed": 17310241, "text": "Myosin IIA negatively regulates cell migration and maintains a balance between the actomyosin and microtubule systems by regulating microtubule dynamics."}, {"pubmed": 17327270, "text": "MIIA plays a role in CXCR4 endocytosis, which involves its dynamic association with beta-arrestin and highlights the role of endogenous MIIA as a regulator of CXCR4 internalization and, therefore, the onset of SDF-1alpha signaling."}, {"pubmed": 17337617, "text": "Pairwise and multilocus haplotype analyses identified linkage disequilibrium between polymorphism alleles at the MYH9 locus and the disease."}, {"pubmed": 17488351, "text": "direct platelet myosin IIA participation in internal contraction"}, {"pubmed": 17567956, "text": "These observations support a direct role for myosin-IIA heavy-chain phosphorylation in mediating motility and chemotaxis."}, {"pubmed": 17645784, "text": "MyosinIIa contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stability"}, {"pubmed": 17875677, "text": "myosin IIA is required for a critical step between NK immunological synapse formation and granule exocytosis"}, {"pubmed": 17901043, "text": "An MYH9 human disease model in flies."}, {"pubmed": 18059020, "text": "subjects with mutations in the motor domain present with severe thrombocytopenia and develop nephritis and deafness before the age of 40, while those with mutations in the tail domain have a much lower risk of complications and higher platelet counts"}, {"pubmed": 18192507, "text": "show the differential expression of mutant NMMHC-IIA and postulate that cell-specific regulation mechanisms function in MYH9 disorders"}, {"pubmed": 18195072, "text": "during T lymphocyte migration, uropodal adhesion depends on LFA-1 avidity, where MyH9 serves as a key mechanical link between LFA-1 and the cytoskeleton that is critical for LFA-1 de-adhesion"}, {"pubmed": 18284620, "text": "first report of a large deletion of the MYH9 gene leading to the development of MYH9 disorders"}, {"pubmed": 18330899, "text": "The effects of MYH9-siRNA-induced suppression underline the critical role of NMHC-IIA in maintenance of cell shape and adhesion."}, {"pubmed": 18332220, "text": "On both RBCs and microbeads, human CD47 potently inhibits phagocytosis as does direct inhibition of myosin. CD47-SIRPalpha interaction initiates a dephosphorylation cascade directed in part at phosphotyrosine in myosin."}, {"pubmed": 18394644, "text": "TRPM7 regulates myosin IIA filament stability and localization by phosphorylating a short stretch of amino acids within the alpha-helical tail of the myosin IIA heavy chain"}, {"pubmed": 18571626, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18571626, "text": "The genes MYH9 might be vulnerability genes for neuropsychologically defined subgroups of schizophrenic patients."}, {"pubmed": 18697221, "text": "Expression of full-length human NMHC-IIA and -IIB in 10 T1/2 cells demonstrated that flectin antibody recognizes both isoforms"}, {"pubmed": 18716610, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18716610, "text": "The highest LOD score was found in chromosomal region 22q12.2-12.3 and the total linkage area spans over 20 cM; this region contains the MYH9 gene, which is expressed in the developing palate."}, {"pubmed": 18752571, "text": "proplatelet formation in human megakaryocytes undergoes a complex spatio-temporal regulation orchestrated by adhesive proteins, GPIb-IX-V and myosin IIA"}, {"pubmed": 18794854, "text": "Genetic variation at the MYH9 locus is associated with nondiabetic end-stage kidney diseases."}, {"pubmed": 18794856, "text": "Genetic variation at the MYH9 locus substantially explains the increased burden of focal segmental glomerulosclerosis and hypertensive end-stage kidney diseases."}, {"pubmed": 18794856, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18812466, "text": "patients developed CLL clones with identical antibody V regions, suggesting selection by a common antigen. Monoclonal antibodies from this stereotypics subset are reactive MYHIIA"}, {"pubmed": 18843042, "text": "Data show that swapping a small C-terminal portion of the tail between myosin IIA and IIB inverts the distinct distribution of these isoforms in migrating cells."}, {"pubmed": 18925516, "text": "Study optimized the conditions and used HRMA for rapid screening of mutations in all MYH9 exons in seven affected individuals from four unrelated families with suspected MYH9 disorders."}, {"pubmed": 18971378, "text": "results demonstrate that both the 6S/10S conformational change and the tailpiece contribute to the localization and assembly of myosin II in mammalian cells"}, {"pubmed": 19147824, "text": "These observations indicate multiple functions for NM IIA which involve previously unrecognized control of intracellular signaling and protein expression."}, {"pubmed": 19153477, "text": "MYH9 variants are associated with albuminuria in hypertensive African Americans."}, {"pubmed": 19153477, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19177153, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19177153, "text": "hypertension-associated ESRD in African Americans is substantially related to MYH9 gene polymorphisms"}, {"pubmed": 19191864, "text": "Double mutations in MYH9 have caused large myosin protein aggregation and accumulation in myosin, resulting in macrothrombocytopenia and conspicuous cytoplasmic inclusion bodies in neutrophils."}, {"pubmed": 19227191, "text": "May-Hegglin anomaly(MHA) is the prototype of the autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies/MYH9 disorders that result from mutations in MYH9, the gene for nonmuscle myosin heavy chain-IIA(NMMHC-IIA)."}, {"pubmed": 19320731, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19320731, "text": "Single marker analysis resulted in a highly significant association for rs7078. In haplotype analysis, the most significant result was obtained for the SNP combination (rs7078; rs2071731; rs739097; rs5995288)."}, {"pubmed": 19387472, "text": "In non-diabetic individuals, serum creatinine was associated with this gene in two of three European populations and in meta-analysis."}, {"pubmed": 19401332, "text": "The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA."}, {"pubmed": 19450438, "text": "Identification of the first duplication in MYHD-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene."}, {"pubmed": 19454694, "text": "NK cell lytic granule-associated myosin IIA enables their interaction with actin and final transit through the actin-rich IS to the synaptic membrane"}, {"pubmed": 19459928, "text": "analysis of three in-frame deletion mutations in MYH9 disorders"}, {"pubmed": 19557653, "text": "immunostaining of NMMHC-IIA in blood samples of selected exons of the MYH9 gene revealed mutations in nine samples with one novel mutation"}, {"pubmed": 19567477, "text": "MYH9 gene polymorphisms are associated with clinically diagnosed T2DM-associated ESRD in African Americans."}, {"pubmed": 19572073, "text": "proplatelets extended by MYH9-RD megakaryocytes presented a significant defect in branching in secondary processes (p=0.001) and formed a significantly lower number of proplatelet tips (p=0.005)"}, {"pubmed": 19645626, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19645626, "text": "conclude that mutations in MYH9 are infrequently found in patients with nonsyndromic deafness and suggest that MYH9 mutations infrequently cause isolated sensorineural hearing loss"}, {"pubmed": 19851296, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19860543, "text": "in a family with eight individuals suffering from macrothrombocytopenia and hearing impairment we identified a novel c.Ala95Asp mutation; affecting the motor domain of the protein, the mutation is likely to be associated with a severe phenotype"}, {"pubmed": 19891592, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19891592, "text": "Risk factors identified in this study may provide a better understanding of the etiological role of MYH9 and influence of environmental factors in nonsyndromic orofacial cleft incidence."}, {"pubmed": 19921264, "text": "Common variants in MYH9 polymorphisms may not confer an increased risk of CKD in American Indian populations."}, {"pubmed": 19921264, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19954613, "text": "The 5797C-->T substitution in MYH9 gene is a pathogenic mutation associated with a non-familial May-Hegglin anomaly."}, {"pubmed": 20002731, "text": "MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype"}, {"pubmed": 20005488, "text": "the majority of HIV-infected patients who are genetically at risk from MYH9 do not appear to develop severe kidney disease"}, {"pubmed": 20124285, "text": "Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15."}, {"pubmed": 20144966, "text": "African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans."}, {"pubmed": 20144966, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20174760, "text": "Myosin-9 inclusions in neutrophils are a pathognomonic sign of heavy chain myosin 9-related disease."}, {"pubmed": 20188514, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20188514, "text": "The results of this study suggested that MYH9 does not confer increased susceptibility to schizophrenia in the Japanese population."}, {"pubmed": 20198315, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20200500, "text": "MYH9 R702 mutations display a strict genotype-phenotype correlation, and lead to the rapid deterioration of podocyte structure"}, {"pubmed": 20221761, "text": "Results describe the mutational status of the MYH9 gene in five German families with suspected MYH9-related disease."}, {"pubmed": 20299374, "text": "Review: MYH9 risk variants exhibit the most impressive association with any common complex kidney disease yet identified."}, {"pubmed": 20347641, "text": "The strong predicted power of MYH9 variation for disease indicates a clear role for genetic testing for these variants in personalized medicine, for assessment of genetic risk, and potentially for diagnosis"}, {"pubmed": 20416459, "text": "MYH9(R705H)-induced altered phenotype of the MDA-MB-231 cell line supports the pathogenicity of the mutation and represents a suitable assay system for identification and characterization of its dysfunction."}, {"pubmed": 20492585, "text": "MYH9 polymorphisms may affect treatment outcomes in severe kidney disease and such gene effects are rarely encountered in practice."}, {"pubmed": 20523037, "text": "MYH9 does not contribute substantially to the development of lupus nephrotis in African Americans"}, {"pubmed": 20523037, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20532800, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20603234, "text": "a novel c.3485G > C mutation in the last nucleotide of exon 25 in two families with macrothrombocytopenia"}, {"pubmed": 20634883, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20634883, "text": "The population-specific divergence in MYH9 risk allele frequencies among the world's populations may prove important in risk assessment and public health policies to mitigate the burden of kidney disease in vulnerable populations."}, {"pubmed": 20635188, "text": "missense mutations with predicted functional effects in the APOL1 gene are significantly more associated with ESKD than all previously reported SNPs in MYH9"}, {"pubmed": 20668430, "text": "A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9."}, {"pubmed": 20668430, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20723023, "text": "mutated non-muscle myosin IIA can lead to thrombocytopenia in mice and humans"}, {"pubmed": 20844233, "text": "MYH9 mutations are associated with thrombocytopenia."}, {"pubmed": 20944748, "text": "non-muscle myosin heavy chain IIA (NMHC-IIA), a subunit of non-muscle myosin IIA (NM-IIA), functions as an HSV-1 entry receptor by interacting with gB"}, {"pubmed": 21083612, "text": "May-Hegglin anomaly E1841K mutation, homozygous in father and heterozygous in son"}, {"pubmed": 21106542, "text": "Results suggest that IIA and IIB can form hetero-filaments in an isoform-independent manner, and that a factor like Mts1 can remove one isoform from the hetero-filament, resulting in a formation of homo-filaments consisting of another isoform."}, {"pubmed": 21110983, "text": "Using peptide competition assays and NMR spectroscopy, we conclude that the minimal binding site on myosin heavy chain IIA corresponds to A1907-G1938; therefore, the site extends beyond the end of the coiled-coil region of myosin."}, {"pubmed": 21184743, "text": "MYH9 is required for lamellipodia formation since it provides contractile forces and tension for the F-actin network to form convex arcs at the leading edge through constitutive binding to WAVE2 and colocalization with PIP(3) in response to IGF-I."}, {"pubmed": 21210153, "text": "mutations in the motor domain of non-muscle myosin heavy chain IIA and negative family history were associated with severe renal involvement in patients with MYH9-related disorders"}, {"pubmed": 21245129, "text": "Polymorphisms in the nonmuscle myosin heavy chain 9 gene are associated with the progression of IgA nephropathy."}, {"pubmed": 21380797, "text": "Suggest that the putative circulating factor in idiopathic focal segmental glomerulosclerosis disrupts normal NMMHC-IIA function in podocytes and might contribute to the pathogenesis of recurrent FSGS."}, {"pubmed": 21429915, "text": "MYH9 polymorphism rs4821480 is associated with an increased risk of non-diabetic CKD in individuals of European ancestry."}, {"pubmed": 21533124, "text": "study demonstrated that overexpression of let-7f in gastric cancer could inhibit invasion and migration of gastric cancer cells through directly targeting the tumor metastasis-associated gene MYH9"}, {"pubmed": 21537348, "text": "MYH9 was initially thought to harbor mutations, but the neighboring gene APO1 was subsequentyly identified as being more strongly associated with kidney disease."}, {"pubmed": 21567368, "text": "This review provides a workflow for diagnosis and treatment of MYH9 related thrombocytopenia."}, {"pubmed": 21667320, "text": "Changes in PKC iota, PKC zeta, and non-muscle MyoIIA expression are likely to participate in pathogenesis of epithelial barrier function in response to local pro-inflammatory signals."}, {"pubmed": 21698141, "text": "FRMD3 SNPs appeared to interact with the MYH9 E1 haplotype"}, {"pubmed": 21721535, "text": "Cross-linking and titration data indicate that the S100A4 dimer binds a single myosin-IIA target peptide. These data are consistent with a model in which a single peptide forms interactions in vicinity of canonical target binding cleft of each monomer"}, {"pubmed": 21792479, "text": "Increased NMM (nonmuscle myosin II) IIA, NMM IIB and AT expression in keloid fibroblasts compared with scant staining in normal surrounding dermis, is reported."}, {"pubmed": 21796764, "text": "MYH9 mutation is associated with thrombocytopenia."}, {"pubmed": 21805244, "text": "Myosin heavy polypeptide 9 is a new downstream effector of proprotein convertases in the human colon cancer cells HT-29."}, {"pubmed": 21826056, "text": "Etiology of nodular fasciitis seems to involve USP6 transcriptional upregulation due to its fusion with a strong ectopic promoter (MYH9)."}, {"pubmed": 21833445, "text": "mutations responsible for gene-related thrombocytopenia impair megakaryoblast migration during thrombopoiesis"}, {"pubmed": 21910715, "text": "Data provide insight into the pathobiology of renal dysfunction in SCD, suggesting that MYH9 and APOL1 are both associated with risk."}, {"pubmed": 21951916, "text": "findings indicate that overexpression of myosin IIA may contribute to the progression and poor prognosis of esophageal squamous cancer, and this effect may be associated with increased cancer cell migration."}, {"pubmed": 21968013, "text": "Polymorphisms in MYH9 are associated with diabetic nephropathy."}, {"pubmed": 22080149, "text": "Large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts."}, {"pubmed": 22123909, "text": "Single myosin IIA molecules associate with NK-cell lytic granules via the nonhelical tailpiece. Phosphorylation of myosin IIA at residue serine 1943 (S1943) in the tailpiece is needed for this linkage."}, {"pubmed": 22161839, "text": "Experimental inhibition of NMIIA by reducing either its expression (via stable shRNA transduction) or its function (via the specific ATPase inhibitor blebbistatin) underpinned the decisive role of NMIIA in MCF-7 cell invasion."}, {"pubmed": 22189356, "text": "No association between Lupus nephritis (LN) and MYH9 was found in African-Americans (AAs), Asians, Amerindians or Hispanics."}, {"pubmed": 22253476, "text": "data reveal NM-IIA as a key cytoskeleton motor protein that facilitates vesicle trafficking during MG53-mediated cell membrane repair"}, {"pubmed": 22313957, "text": "MYH9 expression is down-regulated in HIV-1-associated nephropathy."}, {"pubmed": 22372535, "text": "The results confirmed the benign nature of the A1939T MYH9 mutation in a family with Bolzano-type Bernard-Soulier syndrome."}, {"pubmed": 22398565, "text": "Letter/Case Report: prophylactic eltrombopag treatment in severe MYH9-related thrombocytopenia patient undergoing orthopedic surgery."}, {"pubmed": 22399300, "text": "Data show wthat the S100P-induced dissociation of NMIIA filaments leads to a weakening of focal adhesion sites (FAS), reduced cell adhesion, and enhanced cell migration, the first major step in the metastatic cascade."}, {"pubmed": 22460785, "text": "Data suggest that the complex will facilitate the design of specific drugs that interfere with the S100A4-NMIIA interaction."}, {"pubmed": 22477015, "text": "Study describe a Korean patient with May-Hegglin anomaly from a mutation of the MYH9 gene."}, {"pubmed": 22483112, "text": "Asymmetric mode of Ca-S100A4 interaction with nonmuscle myosin IIA generates nanomolar affinity required for filament remodeling in epithelial carcinoma cells."}, {"pubmed": 22541678, "text": "Case Report: identified an in-frame deletion mutation in exon 24 of the MYH9 gene resulting in MYH9 disorder and end stage renal failure."}, {"pubmed": 22558294, "text": "Elevation of liver enzymes is a frequent and previously unrecognized feature of the MYH9MYH9-related disease syndrome."}, {"pubmed": 22806255, "text": "Chronic transaminase elevation may be present in MYH9 syndrome."}, {"pubmed": 22895805, "text": "expression of NMHC IIA mRNA was higher in bladder cancer compared to the adjacent normal tissues; detection of NMHC IIA protein expression is potentially useful in prognostic evaluation of cystectomy candidates with early-stage bladder cancer"}, {"pubmed": 22934964, "text": "SRX forms a complex with S100A4 (and has stronger affinity for S-glutathionylated S100A4), regulates its activity, and mediates redox regulation of the interaction of S100A4 with nonmuscle myosin heavy chain II-A."}, {"pubmed": 22956460, "text": "We did not observe significant evidence of association between non-diabetic CKD and any of the MYH9 variants or haplotypes after accounting for multiple testing in our sample"}, {"pubmed": 22967416, "text": "Four MYH9 gene mutations were found in six patients with thrombocytopenia with giant platelets and granulocyte inclusions."}, {"pubmed": 22989438, "text": "Mutation of MYH9 gene may be the molecular mechanism of MYH9-related syndrome."}, {"pubmed": 23068101, "text": "These results suggest that MYBPH inhibits RLC and NMHC IIA, independent components of NM IIA, and negatively regulates actomyosin organization at 2 distinct steps, resulting in firm inhibition of NM IIA assembly."}, {"pubmed": 23083320, "text": "The expression of non-muscle myosin IIA (MYH9)was also significantly upregulated in neutrophils."}, {"pubmed": 23123319, "text": "A report on five families with MYH9-related disease, each with a novel MYH9 mutation."}, {"pubmed": 23128239, "text": "The MIIA has a key upstream role: in cells on soft matrix, MIIA appeared diffuse and mobile, whereas on stiff matrix, MIIA was strongly assembled in oriented stress fibers that MIIB then polarized."}, {"pubmed": 23203126, "text": "These findings indicate that overexpression of NMIIA may contribute to the progression and poor prognosis of GC."}, {"pubmed": 23207509, "text": "10 unrelated patients with MYH9-related disease in whom the following seven MYH9 gene mutations were found: W33R, p.Q1443_K1445dup, R702H, D1424N, E1841K, R1933X, and E1945X. clinical expression can vary between individuals with the same mutation"}, {"pubmed": 23285077, "text": "MYH9 may have a broader genetic risk effect on kidney diseases."}, {"pubmed": 23306907, "text": "Intrafusal myosin heavy chain expression of human masseter and biceps muscles at young age shows fundamental similarities but also marked differences."}, {"pubmed": 23396488, "text": "Golgi fragmentation is accompanied by the increased association of NMIIA with C2GnT-M and its degradation by proteasomes."}, {"pubmed": 23409987, "text": "Heterozygous MYH9 S96L mutations were found in a patient and his father, resulting in the diagnosis of a familial case with MYH9 disorders."}, {"pubmed": 23470845, "text": "MYH9 polymorphism (rs3752462) is associated with renal function in the Spanish RENASTUR cohort."}, {"pubmed": 23516419, "text": "MYH9 is an important gene per se, predisposing to CKD, suggesting its usefulness as a prognostic marker for young hematuric patients."}, {"pubmed": 23594493, "text": "Rare variants identified in MYH9 from exome sequence in a large pedigree with autism is not predicted to have a functional effect"}, {"pubmed": 23990450, "text": "NMIIA is the master regulator of Golgi fragmentation induced by heat shock or inhibition/depletion of HSP70/90 through interaction with gylosyltransferases."}, {"pubmed": 24011553, "text": "Possible genetic association link between keloids, non-diabetic kidney disease, and the APOL1-MYH9 haplotype amongst those of African descent."}, {"pubmed": 24042022, "text": "Low non-muscle myosin IIA protein, human expression is associated with focal segmental glomerulosclerosis."}, {"pubmed": 24072716, "text": "The data show that although NM IIA and IIB form filaments with similar properties, NM IIC forms filaments that are less well suited to roles such as tension maintenance within the cell."}, {"pubmed": 24165359, "text": "results show that in MYH9-RD, mutations modify the overall MYH9 function and provoke a proplatelet defect through an excess of actomyosin contractility in spreading MKs"}, {"pubmed": 24243973, "text": "The distribution of organelles within platelets critically depends on a homogeneous organelle distribution within megakaryocytes and preplatelet fragments, which requires myosin IIA."}, {"pubmed": 24436421, "text": "In human and mouse keratinocytes, myosin IIa's function is manifested not only in conventional actin-related processes but also in regulating posttranscriptional p53 stabilization."}, {"pubmed": 24468067, "text": "Myosin IIa activation and galectin-1 endocytosis are important in tumor associated tDC development"}, {"pubmed": 24596217, "text": "Data provide support for an unexpected tumor-suppressive role for myosin IIa in Squamous cell carcinoma that is associated with regulation of p53 nuclear accumulation."}, {"pubmed": 24643058, "text": "A 4-generation pedigree segregating a V1516L mutation in MYH9 is described. Other pathogenic mutations of this gene are reviewed."}, {"pubmed": 24658608, "text": "MYH9 gene polymorphisms confer an increased risk of chronic kidney disease in lupus nephritis patients, independently of race."}, {"pubmed": 24890873, "text": "R705H mutation of MYH9 is associated with MYH9-related disease characterized by hearing impairment, thrombocytopenia, giant platelets, leukocyte inclusions, and mild to moderate elevation of some liver enzymes"}, {"pubmed": 24949636, "text": "we tested the effect of loss of MYH9 expression in podocytes in vitro, and found that it was necessary for cytoskeletal organization"}, {"pubmed": 24989342, "text": "the role of myosin IIA and its specific kinase, myosin light chain kinase, during Shigella intercellular spreading was investigated in HeLa cells"}, {"pubmed": 25127216, "text": "Matrix stiffness couples to myosin-II activity to promote lamin-A,C dephosphorylation at Ser22, which regulates turnover, lamina physical properties, and actomyosin expression. Lamin-A,C phosphorylation is low in interphase versus dividing cells."}, {"pubmed": 25395423, "text": "Myosin-II repression is associated with macrothrombocytopenia."}, {"pubmed": 25424224, "text": "One complicating factor in this case is the diagnosis of MYH9RD in this patient."}, {"pubmed": 25544611, "text": "Whereas most nonmuscle myosin IIA (MIIA) at the leading edge assembled into dorsal contractile arcs, a substantial subset assembled in or was captured within maturing focal adhesions, and this behavior was promoted by active Rac1."}, {"pubmed": 25605255, "text": "High myosin-9 expression is associated with esophageal squamous cell carcinoma."}, {"pubmed": 25621949, "text": "The role of myosin II in shape control of invasive cells migrating in 3D collagen gels, was studied."}, {"pubmed": 25621953, "text": "Progressive accumulation of myosin II to the mitotic cell cortex probably requires the Cdk1 activation of both p21-activated kinases, which inhibit myosin recruitment, and of Rho kinase, which stimulates myosin recruitment to the cortex."}, {"pubmed": 25635050, "text": "A novel mechanism of regulation of NMHC-IIA activity relying on the phosphorylation of Tyr-158 by Src."}, {"pubmed": 25730040, "text": "MYH9 gene polymorphisms may be associated with multiple cerebrovascular blood flow phenotypes in Chinese patients with type 2 diabetes"}, {"pubmed": 25826333, "text": "revealed that MYH9 is expressed in a subset of NSCLC with a more malignant nature, and its expression is an indicator of a poorer survival probability"}, {"pubmed": 25881103, "text": "Inhibition of NMMHC IIA impedes TF expression and venous thrombosis via Akt/GSK3beta-NF-kappaB signalling pathways in the endothelium both in vitro and in vivo."}, {"pubmed": 26051904, "text": "A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia."}, {"pubmed": 26056797, "text": "MYH9 p.R1165C mutation is associated with MYH9 Disorder."}, {"pubmed": 26136073, "text": "myosin IIA and IIB heavy chains play distinct and non-redundant roles in matrix remodeling"}, {"pubmed": 26147622, "text": "concordant with the genetic interaction observed in sickle cell disease patients, APOL1 G2 reduces myh9 expression in vivo, suggesting a possible interaction between the altered APOL1 and myh9."}, {"pubmed": 26152646, "text": "heterozygotic form (allele A) of the MYH9 gene could be considered a very early marker, a new risk factor for the appearance of CKD, or a sign of renal frailty in elderly people."}, {"pubmed": 26226608, "text": "Severity and progression of sensorineural hearing loss appeared to depend on the specific NMMHC-IIA mutation in patients with MYH9-related disease."}, {"pubmed": 26368311, "text": "Data show that myosin II supports a stable Rho zone at the at E-cadherin junctions."}, {"pubmed": 26499037, "text": "Knocking down myosin-9 or promoting protein S-glutathionylation by knocking down glutaredoxin-1 inhibited the death of airway smooth muscle cells by heating to simulate bronchial thermoplasty"}, {"pubmed": 26719067, "text": "the present study indicated that knockdown of NMIIA inhibited the migration and invasion of gastric cancer cells, which may be, at least in part, mediated via the JNK signaling pathway."}, {"pubmed": 26823606, "text": "HhnRNP-K-mediated regulation of NMHC IIA mRNA translation contributes to the control of enucleation in erythropoiesis."}, {"pubmed": 26861218, "text": "7 members in 3 generations of a family had macrothrombocytopenia without Alport syndrome, and they all had a p.A95V mutation in exon 1 of MYH9. This affects the motor domain."}, {"pubmed": 26942920, "text": "The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family."}, {"pubmed": 27169898, "text": "ALPK1 is a kinase that participates in the regulation of Golgi-derived TNF-alpha trafficking through myosin IIA phosphorylation in the inflammation of gout."}, {"pubmed": 27350172, "text": "The tumor microenvironment can regulate NMIIA in cancer cells."}, {"pubmed": 27374701, "text": "The Raf-ERK1/2 signaling pathway is involved in regulation of NMIIA by DT-13."}, {"pubmed": 27437869, "text": "we present high MYH9 expression as a reliable and powerful prognostic factor for patients with AML."}, {"pubmed": 27496447, "text": "Our study is the first to identify genetic predisposition to transplant renal artery stenosis in patients with MYH9 risk allelic variants (rs4821480, rs4821481, rs3752462, rs11089788, rs136211, rs5756168, rs2032487, and rs2239784)"}, {"pubmed": 27527345, "text": "Results identified nonsynonymous variants in MYH9 and ABCA4 to be the most frequent risk loci in nonsyndromic orofacial clefts in the Taiwanese population."}, {"pubmed": 27577209, "text": "Data show that a heterozygous missense mutation c.4270G>A (p.Aspl841Asn) in exon 30 of the non-muscle myosin heavy chain 9 (MYH9) gene was identified in all affected members from thE family."}, {"pubmed": 27634189, "text": "mass spectrum followed by immunoprecipitation identified non-muscle myosin heavy chain-IIA (NMMHC-IIA) as the CXCR4-interacting protein. Furthermore, pharmaceutical inhibition of NMMHC-IIA by blebbistatin dampened the nuclear translocation of CXCR4 as well as the metastatic capacity of RCC cells"}, {"pubmed": 27650961, "text": "The loss of junctional NMIIA, upon Coronin 1B knockdown, perturbed RhoA signaling."}, {"pubmed": 27737892, "text": "cytokinesis failure in megakaryocytes is the consequence of both the absence of NMIIB and a low RhoA activity that impairs NMIIA localization at the cleavage furrow through increased actin turnover."}, {"pubmed": 27824130, "text": "MYO18A has the potential to form a multiprotein complex that links the Golgi apparatus to F-actin, which regulates muscle integrity and function during early development"}, {"pubmed": 27924804, "text": "The rs3752462 polymorphism of MYH9 is associated with high systolic blood pressure in patients with CKD. The T allele in the dominant model was associated with an elevated risk for high systolic blood pressure ."}, {"pubmed": 28049826, "text": "Report that PTCSC2 binds myosin-9 (MYH9). In a bidirectional promoter shared by FOXE1 and PTCSC2, MYH9 inhibits the promoter activity in both directions. This inhibition can be reversed by PTCSC2, which acts as a suppressor."}, {"pubmed": 28160562, "text": "Findings suggest that the tumor suppressor capability of wtp53 is dependent upon functional NMIIA and that the invasive phenotype of high-risk mutp53 is independent of NMIIA."}, {"pubmed": 28293712, "text": "A missense mutation (c.1124C>T:p.S375F) was found in a congenital thrombocytopenia patient and his affected mother. It was associated with abnormal neutrophil NMMHC-IIA localization."}, {"pubmed": 28361956, "text": "In neutrophilic leucocytes from MYH9-related disease patients NMIIa inclusions are accompanied by increased lipid storage in droplets, suggesting that NMIIa dysfunction may contribute to lipid imbalance in man."}, {"pubmed": 28368695, "text": "Mutations of MYH9 cause MYH9-RD, a form of congenital thrombocytopenia characterized by giant platelets and no platelet functional abnormalities."}, {"pubmed": 28604953, "text": "Heterozygous deletional mutation (c.5803delG) in exon 41 of the MYH9 gene is associated with inherited thrombocytopenia."}, {"pubmed": 28900514, "text": "miR-647 functions as a tumor metastasis suppressor in gastric cancer by targeting SRF/MYH9 axis."}, {"pubmed": 29090586, "text": "Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia have been reported."}, {"pubmed": 29093437, "text": "Results suggest that coupling between actin and microtubule cytoskeletons driven by Myosin II and KIF20A ensures the spatial coordination between RAB6-positive vesicles fission from Golgi/trans-Golgi network membranes and their exit along microtubules."}, {"pubmed": 29207917, "text": "2 SNPs of MYH9, rs12107 in the 3'UTR and rs2269529 in the coding region, are associated with increased risk of NSOCs and their subphenotypes in a Chinese population. These variants may contribute to the onset of NSOCs by increasing the expression level of MYH9."}, {"pubmed": 29208598, "text": "Myosin IIa as a physiological regulator of endothelial von Willebrand factor secretion in stress-induced hemostasis and thrombosis."}, {"pubmed": 29438440, "text": "demonstrated that though the targeted integration site for exogenous genes is shifted to MYH9 intron 2 (about 500bp downstream exon 2), the high HR efficiency and the endogenous MYH9 gene integrity are not only preserved, but the expected expression of the inserted gene(s) is observed in a pre-designed set of experiments conducted in mouse ES cells"}, {"pubmed": 29467250, "text": "Myosin IIA and IIB are essential for the formation of transverse arcs and ventral stress fibers, respectively. Furthermore, the study illustrated the roles of both isoforms in lamellar flattening and also raised the possibility that actin filaments in ventral stress fibers are in a stretched conformation."}, {"pubmed": 29486156, "text": "These distinct functions of NMIIA and NMIIB might promote intrinsic and directed migration of normal human fibroblasts."}, {"pubmed": 29545013, "text": "The overall purpose of this review is to point out that important progresses have been made in understanding the pathogenesis of ANKRD26-Related Thrombocytopenia and MYH9-Related Diseases and new therapeutic approaches have been proposed and tested."}, {"pubmed": 29862302, "text": "Our results suggest that MYH9 rs3752462 is significantly associated with an increased risk of diabetic kidney disease in Chinese Han individuals."}, {"pubmed": 29903892, "text": "A germline de novo MYH9 mutation was identified in a newborn with congenital hemangioma."}, {"pubmed": 29956586, "text": "These results indicate that nonmuscle myosin heavy chain-IIs interact with sodium channel alpha subunits subunits in an isoform-dependent manner and influence their functional properties."}, {"pubmed": 29996171, "text": "This study reports four novel MYH9 mutations affecting the tail domain of NMMHC-IIA and responsible for MYH9-RD in four families. Two variants cause amino acid substitutions in the coiled-coil region of NMMHC-IIA, while the other two are a splicing variant and a single nucleotide deletion both resulting in frameshift alterations of the short non-helical tailpiece."}, {"pubmed": 30076174, "text": "Non-muscle myosin IIA (NMIIA) in reticulocyte remodeling and suggest a mechanism of shear stress-responsive vesicle clearance that is crucial for reticulocyte maturation."}, {"pubmed": 30199160, "text": "These results suggest that cytoplasmic multimolecular protein complexes containing myosin-9 and tropomyosin are involved in the regulation of cellular response to LYSOPHOSPHATIDIC ACID."}, {"pubmed": 30258071, "text": "results suggest that TFPI-2 suppresses cancer cell proliferation and invasion partly through the regulation of the ERK1/2 signaling and through interactions with myosin-9 and actinin-4."}, {"pubmed": 30336116, "text": "The actomyosin network is influenced by NMHC IIA and regulated by the factor CrpF46, which is involved in the control of cell migration."}, {"pubmed": 30420430, "text": "Molecular modeling/simulation coupled with site-directed mutagenesis revealed that Asp(147) or Asn(169) of RIPK1 are key for ceramide binding and that Arg(258) or Leu(293) residues are involved in the nonmuscle myosin heavy chain II-A interaction, leading to ceramidosome formation and necroptosis."}, {"pubmed": 30529400, "text": "Non-muscle myosin IIA is post-translationally modified by interferon-stimulated gene 15 in breast cancer cells"}, {"pubmed": 30934202, "text": "variant of MYH9 gene is the cause of Fechtner syndrome"}, {"pubmed": 30950024, "text": "c.5521G>A (p.Glu1841Lys) mutation in the MYH9 gene probably underlies the MYH9-related disease in this pedigree"}, {"pubmed": 30954444, "text": "Association between polymorphism rs2032487 in the non-muscle myosin heavy chain IIA gene (MHY9) and chronic kidney disease secondary to type 2 diabetes mellitus in a population of the Canary Islands"}, {"pubmed": 31118506, "text": "Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease."}, {"pubmed": 31486768, "text": "Non-muscle myosin IIA (NMIIA) provides the mechanical tugging force necessary for cell-cell junction reinforcement and maintenance. Non-muscle myosin IIB (NMIIB) is involved in E-cadherin clustering, maintenance of a branched actin layer connecting E-cadherin complexes and perijunctional actin fibers in the biogenesis and integrity of adherens junctions."}, {"pubmed": 31562665, "text": "Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants."}, {"pubmed": 31574082, "text": "myosin crossbridge (CB) kinetics were dramatically slow, characterizing the non-muscle myosin type IIA (NMMIIA) present in myofibroblasts. When MSCs were seeded in solid collagen scaffolds functionalized with Arg-Gly-Asp (RGD), contractility increased and CB kinetics were modified, whereas the unitary NMMIIA-CB force and maximum CB efficiency did not change."}, {"pubmed": 31726371, "text": "LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis."}, {"pubmed": 31735331, "text": "PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma."}, {"pubmed": 31922599, "text": "The c.5521G>A variant of MYH9 gene has co-segregated with the phenotype of May-Hegglin anomaly in this pedigree"}, {"pubmed": 32011449, "text": "rs4821480 in MYH9 was significantly associated with the risk of non-diabetic end-stage renal disease (OR = 3.86; 95%CI: 1.38-10.82, P value .010)"}, {"pubmed": 32056128, "text": "DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations."}, {"pubmed": 32094322, "text": "Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis."}, {"pubmed": 32232887, "text": "results suggested that the 3'-UTR shortening of FNDC3B mRNA mediated its overexpression in nasopharyngeal carcinoma and promoted its progression by targeting MYH9"}, {"pubmed": 32296025, "text": "Silencing MYH9 blocks HBx-induced GSK3beta ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma."}, {"pubmed": 32422910, "text": "Targeting Actomyosin Contractility Suppresses Malignant Phenotypes of Acute Myeloid Leukemia Cells."}, {"pubmed": 32496549, "text": "Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia."}, {"pubmed": 32665550, "text": "NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90."}, {"pubmed": 32685004, "text": "Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis."}, {"pubmed": 32788880, "text": "MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma."}, {"pubmed": 32982961, "text": "CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis."}, {"pubmed": 33220257, "text": "NMIIA promotes tumorigenesis and prevents chemosensitivity in colorectal cancer by activating AMPK/mTOR pathway."}, {"pubmed": 33356805, "text": "Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/beta-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9)."}, {"pubmed": 33415745, "text": "The distinct roles of myosin IIA and IIB under compression stress in nucleus pulposus cells."}, {"pubmed": 33855781, "text": "MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia."}, {"pubmed": 33971927, "text": "Activation of the clock gene TIMELESS by H3k27 acetylation promotes colorectal cancer tumorigenesis by binding to Myosin-9."}, {"pubmed": 34013674, "text": "Novel variant of MYH9 associated with mild evaluation of MYH9 related disorder in a Chinese family."}, {"pubmed": 34297096, "text": "Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1."}, {"pubmed": 34374341, "text": "Distinct roles of nonmuscle myosin II isoforms for establishing tension and elasticity during cell morphodynamics."}, {"pubmed": 34496888, "text": "CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner."}, {"pubmed": 34711031, "text": "[Gene analysis and clinical features of MYH9-related disease]."}, {"pubmed": 34711033, "text": "[Clinical and genetic features of seven children with MYH9-related disease]."}, {"pubmed": 34715250, "text": "Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration."}, {"pubmed": 34887392, "text": "HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3beta via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas."}, {"pubmed": 35147601, "text": "Characterization of Sensorineural Hearing Loss in Patients With MYH9-Related Disease: A Systematic Review."}, {"pubmed": 35309869, "text": "MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis."}, {"pubmed": 35392912, "text": "A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma."}, {"pubmed": 35404999, "text": "A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome."}, {"pubmed": 36030536, "text": "MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis."}, {"pubmed": 36139430, "text": "MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway."}, {"pubmed": 36172865, "text": "Long Noncoding RNA TPRG1-AS1 Suppresses Migration of Vascular Smooth Muscle Cells and Attenuates Atherogenesis via Interacting With MYH9 Protein."}, {"pubmed": 36404341, "text": "A familial case of MYH9 gene mutation associated with multiple functional and structural platelet abnormalities."}, {"pubmed": 36509386, "text": "Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells."}, {"pubmed": 36757050, "text": "SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3beta/beta-Catenin Signaling."}, {"pubmed": 36929633, "text": "MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance."}, {"pubmed": 37069693, "text": "TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC."}, {"pubmed": 37076359, "text": "Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report."}, {"pubmed": 37200287, "text": "HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers."}, {"pubmed": 37202187, "text": "[High expression of MYH9 inhibits apoptosis of non-small cell lung cancer cells through activating the AKT/c-Myc pathway]."}, {"pubmed": 37328958, "text": "Measurement of immature platelet fraction is useful in the differential diagnosis of MYH9 disorders."}, {"pubmed": 37562567, "text": "A brain specific alternatively spliced isoform of nonmuscle myosin IIA lacks its mechanoenzymatic activities."}, {"pubmed": 37594641, "text": "The Potential Impact of MYH9 (rs3752462) and ELMO1 (rs741301) Genetic Variants on the Risk of Nephrotic Syndrome Incidence."}, {"pubmed": 38042490, "text": "Effects of specific disease mutations in non-muscle myosin 2A on its structure and function."}, {"pubmed": 38103735, "text": "Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia."}, {"pubmed": 38181716, "text": "MYH9: A key protein involved in tumor progression and virus-related diseases."}, {"pubmed": 38504374, "text": "TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via beta1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9."}, {"pubmed": 38517106, "text": "Spindle cell neoplasms with novel LTK fusion - Expanding the spectrum of kinase fusion-positive soft tissue tumors."}], "genomic_pos": {"chr": "22", "end": 36388010, "ensemblgene": "ENSG00000100345", "start": 36281280, "strand": -1}, "genomic_pos_hg19": {"chr": "22", "end": 36784063, "start": 36677327, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0000212", "qualifier": "involved_in", "term": "meiotic spindle organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0001525", "pubmed": 16403913, "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001701", "qualifier": "involved_in", "term": "in utero embryonic development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001768", "qualifier": "involved_in", "term": "establishment of T cell polarity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0001778", "pubmed": 27325790, "qualifier": "involved_in", "term": "plasma membrane repair"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006509", "pubmed": 16186248, "qualifier": "involved_in", "term": "membrane protein ectodomain proteolysis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006911", "qualifier": "involved_in", "term": "phagocytosis, engulfment"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007229", "pubmed": 10822899, "qualifier": "involved_in", "term": "integrin-mediated signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007520", "qualifier": "involved_in", "term": "myoblast fusion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008360", "pubmed": 11029059, "qualifier": "involved_in", "term": "regulation of cell shape"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0015031", "pubmed": 16403913, "qualifier": "involved_in", "term": "protein transport"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030036", "pubmed": 15869600, "qualifier": "involved_in", "term": "actin cytoskeleton organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030048", "pubmed": 15845534, "qualifier": "acts_upstream_of_or_within", "term": "actin filament-based movement"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030048", "pubmed": 12237319, "qualifier": "involved_in", "term": "actin filament-based movement"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030220", "pubmed": 12237319, "qualifier": "involved_in", "term": "platelet formation"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0030224", "pubmed": 1912569, "qualifier": "involved_in", "term": "monocyte differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031032", "pubmed": 24072716, "qualifier": "involved_in", "term": "actomyosin structure organization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032418", "pubmed": 2732579, "qualifier": "involved_in", "term": "lysosome localization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032506", "pubmed": 15774463, "qualifier": "involved_in", "term": "cytokinetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032796", "qualifier": "involved_in", "term": "uropod organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035987", "qualifier": "involved_in", "term": "endodermal cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043534", "pubmed": 16403913, "qualifier": "involved_in", "term": "blood vessel endothelial cell migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045055", "pubmed": 2732579, "qualifier": "involved_in", "term": "regulated exocytosis"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0050900", "pubmed": 12421915, "qualifier": "involved_in", "term": "leukocyte migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051295", "qualifier": "involved_in", "term": "establishment of meiotic spindle localization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060471", "qualifier": "involved_in", "term": "cortical granule exocytosis"}, {"evidence": "HMP", "gocategory": "BP", "id": "GO:0070527", "pubmed": 23382103, "qualifier": "involved_in", "term": "platelet aggregation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1903919", "pubmed": 23325791, "qualifier": "involved_in", "term": "negative regulation of actin filament severing"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903919", "qualifier": "involved_in", "term": "negative regulation of actin filament severing"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903923", "qualifier": "involved_in", "term": "positive regulation of protein processing in phagocytic vesicle"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1905684", "pubmed": 2732579, "qualifier": "involved_in", "term": "regulation of plasma membrane repair"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0001725", "pubmed": [7699007, 14508515, 14706930, 15774463, 16403913], "qualifier": "located_in", "term": "stress fiber"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0001726", "pubmed": 16403913, "qualifier": "located_in", "term": "ruffle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0001772", "pubmed": 15064761, "qualifier": "located_in", "term": "immunological synapse"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0001931", "pubmed": 15064761, "qualifier": "located_in", "term": "uropod"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 14508515, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": [7699007, 22693546], "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005819", "qualifier": "located_in", "term": "spindle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005826", "pubmed": 11029059, "qualifier": "located_in", "term": "actomyosin contractile ring"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 14508515, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [16186248, 16403913], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005903", "qualifier": "located_in", "term": "brush border"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005912", "qualifier": "located_in", "term": "adherens junction"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005925", "qualifier": "colocalizes_with", "term": "focal adhesion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0008180", "pubmed": 18850735, "qualifier": "part_of", "term": "COP9 signalosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009898", "pubmed": 15064761, "qualifier": "located_in", "term": "cytoplasmic side of plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0015629", "pubmed": 15869600, "qualifier": "located_in", "term": "actin cytoskeleton"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0016460", "qualifier": "part_of", "term": "myosin II complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016460", "pubmed": 24072716, "qualifier": "part_of", "term": "myosin II complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016604", "qualifier": "located_in", "term": "nuclear body"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0031252", "pubmed": 12421915, "qualifier": "located_in", "term": "cell leading edge"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0031594", "qualifier": "located_in", "term": "neuromuscular junction"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0032154", "pubmed": [7699007, 14508515], "qualifier": "located_in", "term": "cleavage furrow"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0032982", "qualifier": "is_active_in", "term": "myosin filament"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0032991", "pubmed": 12421915, "qualifier": "part_of", "term": "protein-containing complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0042641", "pubmed": 24072716, "qualifier": "located_in", "term": "actomyosin"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0060473", "qualifier": "located_in", "term": "cortical granule"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": [19056867, 19199708, 20458337, 21362503, 23533145], "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0097513", "pubmed": 24072716, "qualifier": "located_in", "term": "myosin II filament"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000146", "qualifier": "enables", "term": "microfilament motor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000146", "pubmed": 24072716, "qualifier": "contributes_to", "term": "microfilament motor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000146", "pubmed": [12237319, 15845534], "qualifier": "enables", "term": "microfilament motor activity"}, {"category": "MF", "evidence": "HDA", "id": "GO:0003723", "pubmed": 22681889, "qualifier": "enables", "term": "RNA binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0003774", "pubmed": 12421915, "qualifier": "enables", "term": "cytoskeletal motor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003779", "pubmed": 15065866, "qualifier": "enables", "term": "actin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005178", "pubmed": 10822899, "qualifier": "enables", "term": "integrin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [2732579, 10822899, 12202484, 12421915, 12577067, 14508515, 14640694, 15171681, 15479433, 16186248, 16403913, 17925381, 18504258, 20421509, 20603131, 20936779, 22229724, 22460785, 22483112, 22693546, 23100250, 24189400, 27325790, 28228547, 31837246, 34873039, 36217030], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005516", "qualifier": "enables", "term": "calmodulin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005524", "pubmed": [15065866, 15845534], "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019904", "pubmed": 23325791, "qualifier": "enables", "term": "protein domain specific binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [22483112, 31837246], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 12237319, "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0043495", "pubmed": 16403913, "qualifier": "enables", "term": "protein-membrane adaptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043531", "pubmed": 15065866, "qualifier": "enables", "term": "ADP binding"}, {"category": "MF", "evidence": "HDA", "id": "GO:0045296", "pubmed": 25468996, "qualifier": "enables", "term": "cadherin binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0051015", "qualifier": "enables", "term": "actin filament binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0051015", "pubmed": 24072716, "qualifier": "contributes_to", "term": "actin filament binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0051015", "pubmed": [12237319, 14508515, 15845534], "qualifier": "enables", "term": "actin filament binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0051015", "pubmed": 16403913, "qualifier": "enables", "term": "actin filament binding"}]}, "homologene": {"genes": [[4896, 2543576], [5141, 3880861], [7955, 333938], [8364, 100487997], [9031, 396469], [9598, 470200], [9606, 4627], [9615, 481280], [9913, 404108], [10090, 17886], [10116, 25745], [318829, 2682613]], "id": 129835}, "interpro": [{"desc": "Myosin head, motor domain", "id": "IPR001609", "short_desc": "Myosin_head_motor_dom"}, {"desc": "Myosin, N-terminal, SH3-like", "id": "IPR004009", "short_desc": "Myosin_N"}, {"desc": "Myosin S1 fragment, N-terminal", "id": "IPR008989", "short_desc": "Myosin_S1_N"}, {"desc": "Kinesin motor domain superfamily", "id": "IPR036961", "short_desc": "Kinesin_motor_dom_sf"}, {"desc": "P-loop containing nucleoside triphosphate hydrolase", "id": "IPR027417", "short_desc": "P-loop_NTPase"}, {"desc": "IQ motif, EF-hand binding site", "id": "IPR000048", "short_desc": "IQ_motif_EF-hand-BS"}, {"desc": "Myosin tail", "id": "IPR002928", "short_desc": "Myosin_tail"}, {"desc": "RGS domain superfamily", "id": "IPR036305", "short_desc": "RGS_sf"}], "ipi": ["IPI00019502", "IPI00395772", "IPI00556012", "IPI00878695"], "map_location": "22q12.3", "name": "myosin heavy chain 9", "other_names": ["cellular myosin heavy chain, type A", "myosin, heavy chain 9, non-muscle", "myosin-9", "non-muscle myosin heavy chain 9", "non-muscle myosin heavy chain A", "non-muscle myosin heavy chain IIa", "non-muscle myosin heavy polypeptide 9", "nonmuscle myosin IIA2", "nonmuscle myosin heavy chain II-A"], "pantherdb": {"HGNC": "7579", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "107717", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 10090, "uniprot_kb": "Q8VDD5"}, {"RGD": "3140", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 10116, "uniprot_kb": "Q62812"}, {"Gene": "MYH9", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 9031, "uniprot_kb": "P14105"}, {"Ensembl": "ENSGALG00000043092", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 9031, "uniprot_kb": "A0A1D5PM19"}, {"ZFIN": "ZDB-GENE-030131-998", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 7955, "uniprot_kb": "F1QC64"}, {"WormBase": "WBGene00003777", "ortholog_type": "O", "panther_family": "PTHR45615", "taxid": 6239, "uniprot_kb": "G5EBY3"}, {"WormBase": "WBGene00003776", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 6239, "uniprot_kb": "Q20641"}, {"FlyBase": "FBgn0000246", "ortholog_type": "O", "panther_family": "PTHR45615", "taxid": 7227, "uniprot_kb": "Q9VF37"}, {"FlyBase": "FBgn0265434", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 7227, "uniprot_kb": "Q99323"}, {"SGD": "S000001065", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 4932, "uniprot_kb": "P08964"}, {"PomBase": "SPAC4A8.05c", "ortholog_type": "O", "panther_family": "PTHR45615", "taxid": 4896, "uniprot_kb": "O14157"}, {"PomBase": "SPCC645.05c", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 4896, "uniprot_kb": "Q9USI6"}, {"dictyBase": "DDB_G0286355", "ortholog_type": "LDO", "panther_family": "PTHR45615", "taxid": 352472, "uniprot_kb": "P08799"}], "uniprot_kb": "P35579"}, "pathway": {"kegg": [{"id": "hsa04270", "name": "Vascular smooth muscle contraction - Homo sapiens (human)"}, {"id": "hsa04530", "name": "Tight junction - Homo sapiens (human)"}, {"id": "hsa04810", "name": "Regulation of actin cytoskeleton - Homo sapiens (human)"}, {"id": "hsa05130", "name": "Pathogenic Escherichia coli infection - Homo sapiens (human)"}], "netpath": {"id": "Pathway_EGFR1", "name": "EGFR1"}, "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1445148", "name": "Translocation of SLC2A4 (GLUT4) to the plasma membrane"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-194315", "name": "Signaling by Rho GTPases"}, {"id": "R-HSA-194315", "name": "Signaling by Rho GTPases"}, {"id": "R-HSA-195258", "name": "RHO GTPase Effectors"}, {"id": "R-HSA-195258", "name": "RHO GTPase Effectors"}, {"id": "R-HSA-199991", "name": "Membrane Trafficking"}, {"id": "R-HSA-2029480", "name": "Fcgamma receptor (FCGR) dependent phagocytosis"}, {"id": "R-HSA-2029482", "name": "Regulation of actin dynamics for phagocytic cup formation"}, {"id": "R-HSA-2682334", "name": "EPH-Ephrin signaling"}, {"id": "R-HSA-373755", "name": "Semaphorin interactions"}, {"id": "R-HSA-3928663", "name": "EPHA-mediated growth cone collapse"}, {"id": "R-HSA-400685", "name": "Sema4D in semaphorin signaling"}, {"id": "R-HSA-416572", "name": "Sema4D induced cell migration and growth-cone collapse"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-5625740", "name": "RHO GTPases activate PKNs"}, {"id": "R-HSA-5625900", "name": "RHO GTPases activate CIT"}, {"id": "R-HSA-5627117", "name": "RHO GTPases Activate ROCKs"}, {"id": "R-HSA-5627123", "name": "RHO GTPases activate PAKs"}, {"id": "R-HSA-5627123", "name": "RHO GTPases activate PAKs"}, {"id": "R-HSA-5653656", "name": "Vesicle-mediated transport"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-9658195", "name": "Leishmania infection"}, {"id": "R-HSA-9659379", "name": "Sensory processing of sound"}, {"id": "R-HSA-9662360", "name": "Sensory processing of sound by inner hair cells of the cochlea"}, {"id": "R-HSA-9662361", "name": "Sensory processing of sound by outer hair cells of the cochlea"}, {"id": "R-HSA-9662834", "name": "CD163 mediating an anti-inflammatory response"}, {"id": "R-HSA-9662851", "name": "Anti-inflammatory response favouring Leishmania parasite infection"}, {"id": "R-HSA-9664407", "name": "Parasite infection"}, {"id": "R-HSA-9664417", "name": "Leishmania phagocytosis"}, {"id": "R-HSA-9664422", "name": "FCGR3A-mediated phagocytosis"}, {"id": "R-HSA-9664433", "name": "Leishmania parasite growth and survival"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9700206", "name": "Signaling by ALK in cancer"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-9716542", "name": "Signaling by Rho GTPases, Miro GTPases and RHOBTB3"}, {"id": "R-HSA-9716542", "name": "Signaling by Rho GTPases, Miro GTPases and RHOBTB3"}, {"id": "R-HSA-9725370", "name": "Signaling by ALK fusions and activated point mutants"}, {"id": "R-HSA-9824443", "name": "Parasitic Infection Pathways"}], "wikipathways": [{"id": "WP2572", "name": "Primary focal segmental glomerulosclerosis (FSGS)"}, {"id": "WP3888", "name": "VEGFA-VEGFR2 Signaling Pathway"}, {"id": "WP4758", "name": "Nephrotic syndrome"}]}, "pdb": ["2LNK", "3ZWH", "4CFQ", "4CFR", "4ETO"], "pfam": ["PF00063", "PF02736", "PF01576"], "pharmgkb": "PA31377", "pharos": {"target_id": 11692, "tdl": "Tbio"}, "pir": "A61231", "prosite": ["PS51456", "PS51844", "PS50096"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF221481", "relationship": "is"}, {"id": "GNF253059", "relationship": "is"}, {"id": "GNF253060", "relationship": "is"}, {"id": "GNF253061", "relationship": "is"}, {"id": "GNF253062", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF160621", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF046647", "relationship": "is"}, {"id": "GNF048090", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF017354", "relationship": "is"}, {"id": "GNF130472", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF095650", "relationship": "is"}, {"id": "GNF135307", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000022.11", "NC_060946.1", "NG_011884.2"], "protein": "NP_002464.1", "rna": "NM_002473.6", "translation": {"protein": "NP_002464.1", "rna": "NM_002473.6"}}, "reporter": {"HG-U133_Plus_2": "211926_s_at", "HG-U95Av2": "39738_at", "HTA-2_0": ["TC22000703.hg.1", "TC22001326.hg.1"], "HuEx-1_0": "3959451", "HuGene-1_1": "8075728", "HuGene-2_1": "16934491"}, "retired": [1695, 50825, 50950, 65212], "summary": "This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011].", "symbol": "MYH9", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1417544"}, "unigene": "Hs.474751", "uniprot": {"Swiss-Prot": "P35579", "TrEMBL": ["A0A8I5KU92", "Q5BKV1", "B1AH99", "A0A8I5KWT8", "A0A8I5KYI1"]}, "wikipedia": {"url_stub": "MYH9"}}